Mechanisms and therapeutic potentials of cancer immunotherapy in combination with radiotherapy and/or chemotherapy
- PMID: 30902563
- DOI: 10.1016/j.canlet.2019.02.048
Mechanisms and therapeutic potentials of cancer immunotherapy in combination with radiotherapy and/or chemotherapy
Abstract
Immunotherapies based on T cells have gained significant success in the treatment of diverse cancers, however, several limitations also exist, including low response, acquired resistance and severe side effects, which lead to unfavorable outcomes. Recent studies found that traditional therapies, radiotherapy and/or chemotherapy may affect the immune condition in situ and cause abscopal effect, which may improve the response of immunotherapies, enhance the efficiency, and reduce the untoward effect. Here, we review the mechanisms uncovering the cancer immunotherapy and immunogenic effects of radiotherapy and chemotherapy, aiming to highlight the principles underlying the therapeutic potentials of cancer immunotherapy in combination with radiotherapy and/or chemotherapy and ultimately guide better designs for future synergistic cancer therapies.
Keywords: Cancer immunity; Chemotherapy; Immunotherapy; Radiotherapy.
Copyright © 2019 Elsevier B.V. All rights reserved.
Similar articles
-
Immunotherapy: enhancing the efficacy of this promising therapeutic in multiple cancers.Clin Sci (Lond). 2019 Jan 18;133(2):181-193. doi: 10.1042/CS20181003. Print 2019 Jan 31. Clin Sci (Lond). 2019. PMID: 30659159 Review.
-
Broadening the Impact of Immunotherapy to Pancreatic Cancer: Challenges and Opportunities.Gastroenterology. 2019 May;156(7):2056-2072. doi: 10.1053/j.gastro.2018.12.038. Epub 2019 Jan 18. Gastroenterology. 2019. PMID: 30660727 Free PMC article. Review.
-
Immunotherapy in hepatocellular carcinoma.Ann Hepatol. 2019 Mar-Apr;18(2):291-297. doi: 10.1016/j.aohep.2019.04.003. Epub 2019 Apr 25. Ann Hepatol. 2019. PMID: 31047849 Review.
-
Immunotherapy of cancer: targeting cancer during active disease or during dormancy?Immunotherapy. 2017 Sep;9(11):943-949. doi: 10.2217/imt-2017-0044. Immunotherapy. 2017. PMID: 29338608 Free PMC article. Review.
-
[Immunotherapies of cancer: Is there any impact on patient cognitive functions?].Med Sci (Paris). 2020 Aug-Sep;36(8-9):695-699. doi: 10.1051/medsci/2020139. Epub 2020 Aug 21. Med Sci (Paris). 2020. PMID: 32821042 French. No abstract available.
Cited by
-
Penile cancer: Updates in systemic therapy.Asian J Urol. 2022 Oct;9(4):374-388. doi: 10.1016/j.ajur.2022.03.006. Epub 2022 May 13. Asian J Urol. 2022. PMID: 36381603 Free PMC article. Review.
-
Identification of tumor microenvironment-associated immunological genes as potent prognostic markers in the cancer genome analysis project HOPE.Mol Clin Oncol. 2021 Nov;15(5):232. doi: 10.3892/mco.2021.2395. Epub 2021 Sep 13. Mol Clin Oncol. 2021. PMID: 34631056 Free PMC article.
-
Crosstalk between HER2 and PD-1/PD-L1 in Breast Cancer: From Clinical Applications to Mathematical Models.Cancers (Basel). 2020 Mar 10;12(3):636. doi: 10.3390/cancers12030636. Cancers (Basel). 2020. PMID: 32164163 Free PMC article. Review.
-
Revalidation of the ATTRACTION-4 study in a real-world setting: a multicenter, retrospective propensity score matching study in China.Front Immunol. 2023 Sep 15;14:1264929. doi: 10.3389/fimmu.2023.1264929. eCollection 2023. Front Immunol. 2023. PMID: 37786611 Free PMC article.
-
Endostar and chemoradiotherapy for advanced cervical cancer: comparing efficacy and prognosis.Am J Transl Res. 2025 Feb 15;17(2):1388-1401. doi: 10.62347/PJVO5304. eCollection 2025. Am J Transl Res. 2025. PMID: 40092089 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources